FDA phasing out animal testing for monoclonal antibodies and other drugs, NAMs as part of the solution for the simplification of REACH, AI-enabled precision medicine drug discovery and more

NAMs News

Actus des méthodes non-animales

APRIL 14 - 18, 2025

FDA phasing out animal testing for monoclonal antibodies and other drugs, NAMs as part of the solution for the simplification of REACH, AI-enabled precision medicine drug discovery and more
Donate